CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 33852 | FprEN ISO 15193 | In vitro diagnostic medical devices - Measurement of quantities in samples of biological origin - Requirements for content and presentation of reference measurement procedures (ISO 15193:2009) | Izstrādē |
| 60920 | prEN ISO 15197 rev | In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Izstrādē |
| 61691 | EN ISO 20166-3:2019 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue - Part 3: Isolated DNA (ISO/DIS 20166-3:2016) | Izstrādē |
| 70355 | EN ISO 20776-2:2022 | Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test - Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution (ISO/DIS 20776-2:2021) | Izstrādē |
| 39676 | - | Molecular in-vitro diagnostic examinations - Specifications for pre-examination processes for selected types of sample | Izstrādē |
| 81156 | prEN ISO 15197 rev | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Izstrādē |
| 5111 | EN 14136:2004 | Use of external quality assessment schemes in the assessment of the performance of in vitro diagnostic examination procedures | Izstrādē |
| 5089 | - | Methods for the determination of performance of culture media | Izstrādē |
| 78870 | EN ISO 15197:2015/prA11 | In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Izstrādē |
| 64589 | - | Molecular in vitro diagnostic examinations - Specifications for preexamination processes for saliva - Isolated DNA | Izstrādē |
Displaying 221-230 of 276 results.